- Home
- TSAT vs SOPH Comparison
TSAT vs SOPH Comparison
Compare TSAT & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TSAT | SOPH |
|---|---|---|
| Founded | 1969 | 2011 |
| Country | Canada | Switzerland |
| Employees | 610 | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.1M | 367.7M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TSAT | SOPH |
|---|---|---|
| Price | $26.03 | $4.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 230.4K | ★ 358.3K |
| Earning Date | 03-26-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $324,440,552.00 | $73,297,000.00 |
| Revenue This Year | N/A | $18.48 |
| Revenue Next Year | N/A | $15.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $14.77 | $2.58 |
| 52 Week High | $36.85 | $5.70 |
Technical Indicators
Market Signals| Indicator | TSAT | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 44.65 |
| Support Level | $25.28 | $4.61 |
| Resistance Level | $28.95 | $5.06 |
| Average True Range (ATR) | 2.26 | 0.30 |
| MACD | -0.18 | -0.06 |
| Stochastic Oscillator | 40.98 | 20.83 |
Price Performance
Historical ComparisonAbout TSAT Telesat Corporation
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.